However, mLOAd703 alone could delay tumor growth in three out of five mice, and the combination with anti-PD-1, anti-PD-L1, and anti-TIM-3 delayed tumor growth in four to five out of five mice depending on the combination. Here, HAVCR2 is linked to neoplasm.